Characteristic | Group I, n = 78 | Group II, n = 71 | p |
---|---|---|---|
Operation time, min | 141.5 (101–153) | 84.3 (54.2–93.7) | 0.002 |
Bleeding, n (%) | 7 (8.9) | 1 (1.4) | 0.035 |
Residual fragments of meshes, n (%) | 13 (16.6) | 1 (1.4) | 0.003 |
Eventration, n (%) | 3 (3.8) | 0 (0.0) | 0.003 |
LHS, days | 14 (7–23) | 7 (3–18) | 0.001 |
SOI, days | 1 (0–6) | 1 (5–14) | 0.016 |
SSI, n (%) | 9 (11.5) | 2 (2.8) | 0.044 |
Characteristic | Group I, n = 78 | Group II, n = 71 | p |
---|---|---|---|
Age, years | 30.7 (8.8–84.1) | 39.4 (6.1–87.7) | 0.037 |
Gender, M/F | 23/55 | 20/51 | 0.653 |
Time between operation, month | 9.2 (6.5–11.3) | 8.4 (7.1–10.2) | 0.7 |
WBC (103/μL) | 12.3 (4.3–26.5) | 13.0 (4.4–36.4) | 0.160 |
Alb (g/dL) | 4.4 (2.8–5.3) | 4.4 (2.5–5.3) | 0.154 |
Neutro. (%) | 80.9 (43.0–95.5) | 83.6 (27.6–95.5) | 0.674 |
Lymph (%) | 13.0 (3–46) | 10.9 (3–57.8) | 0.666 |
Reherniation | Group 1 (n=78) | Group II (n=71) | p |
---|---|---|---|
Patients, n (%) | 11 (14.1) | 6 (8.5) | 0.002 |
Indicators | Group I (n=78) | Group II (n=71) | Odd ratio | 95% CI | p |
---|---|---|---|---|---|
Bleeding, n (%) | 7 (8.9) | 1 (1.4) | 2.29 | 1.04–4.97 | 0.035 |
LHS, days | 14 (7–23) | 7 (3–18) | 2.03 | 1.12–3.71 | 0.001 |
Reherniation, n (%) | 11 (14.1) | 6 (8.5) | 2.4 | 1.09–3.92 | 0.002 |